| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8714119 | The Journal of Allergy and Clinical Immunology: In Practice | 2018 | 6 Pages |
Abstract
Our data strongly suggest that a fuDPT is safe and useful to assess tolerance acquisition in children with a confirmed benign nonimmediate BL allergy. In addition, our results support the use of a short DPT protocol (2 days), which led to a high NPV of 96.7% in our population, with a favorable benefit-risk balance.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Aude MD, Marine MD, Philippe A. MD, Jean-Christoph MD,